jan 1, 2014 - $100 million from Alexion Pharmaceuticals
Description:
Alexion Pharmaceuticals paid Moderna $100 million for ten product options to develop rare disease treatments, including for Crigler-Najjar syndrome, using Moderna's mRNA therapeutics platform
Added to timeline:
Date: